| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |